Foundation Harsaul - Net Worth and Insider Trading

Foundation Harsaul Net Worth

The estimated net worth of Foundation Harsaul is at least $2,471 dollars as of 2024-06-06. Foundation Harsaul is the 10% Owner of RVL Pharmaceuticals PLC and owns about 4,941,101 shares of RVL Pharmaceuticals PLC (RVLPQ) stock worth over $2,471. Details can be seen in Foundation Harsaul's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Foundation Harsaul has not made any transactions after 2023-10-20 and currently still holds the listed stock(s).

Transaction Summary of Foundation Harsaul

To

Foundation Harsaul Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Foundation Harsaul owns 1 companies in total, including RVL Pharmaceuticals PLC (RVLPQ) .

Click here to see the complete history of Foundation Harsaul’s form 4 insider trades.

Insider Ownership Summary of Foundation Harsaul

Ticker Comapny Transaction Date Type of Owner
RVLPQ RVL Pharmaceuticals PLC 2023-10-20 10 percent owner

Foundation Harsaul Latest Holdings Summary

Foundation Harsaul currently owns a total of 1 stock. Foundation Harsaul owns 4,941,101 shares of RVL Pharmaceuticals PLC (RVLPQ) as of October 20, 2023, with a value of $2,471.

Latest Holdings of Foundation Harsaul

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RVLPQ RVL Pharmaceuticals PLC 2023-10-20 4,941,101 0.00 2,471

Holding Weightings of Foundation Harsaul


Foundation Harsaul Form 4 Trading Tracker

According to the SEC Form 4 filings, Foundation Harsaul has made a total of 3 transactions in RVL Pharmaceuticals PLC (RVLPQ) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in RVL Pharmaceuticals PLC is the sale of 14,122,659 shares on October 20, 2023, which brought Foundation Harsaul around $564,906.

Insider Trading History of Foundation Harsaul

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Foundation Harsaul Trading Performance

GuruFocus tracks the stock performance after each of Foundation Harsaul's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Foundation Harsaul is -23%. GuruFocus also compares Foundation Harsaul's trading performance to market benchmark return within the same time period. The performance of stocks bought by Foundation Harsaul within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Foundation Harsaul's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Foundation Harsaul

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.8 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 0.19 LIMIT LIMIT LIMIT LIMIT LIMIT

Foundation Harsaul Ownership Network

Ownership Network List of Foundation Harsaul

No Data

Ownership Network Relation of Foundation Harsaul

Insider Network Chart

Foundation Harsaul Owned Company Details

What does RVL Pharmaceuticals PLC do?

Who are the key executives at RVL Pharmaceuticals PLC?

Foundation Harsaul is the 10 percent owner of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Altchem Ltd , director & 10 percent owner David F Burgstahler , and 10 percent owner Athyrium Opportunities Associates Iv Co-invest Llc .

RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary

Over the past 18 months, Foundation Harsaul made 2 insider transaction in RVL Pharmaceuticals PLC (RVLPQ) with a net sale of 17,544,196. Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Altchem Ltd ,

In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.

RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

RVL Pharmaceuticals PLC Insider Transactions

No Available Data

Foundation Harsaul Mailing Address

Above is the net worth, insider trading, and ownership report for Foundation Harsaul. You might contact Foundation Harsaul via mailing address: Edificio Afra, Avenida Samuel Lewis Y Calle 54, Panama R1.

Discussions on Foundation Harsaul

No discussions yet.